{"transactions":[{"id":689264,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-08-12T23:33:08.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":false,"shares":2170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests as to 25% of the total number of shares of Common Stock subject to the option on the first anniversary of the grant date, and as to 1/48th of  the total number of shares of Common Stock subject to the option on each monthly anniversary thereafter."}],"balance_after":13024,"derivative":{"exercise_price":16,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":2170},"source":{"system":"sec-edgar","filing":"0001933414-26-000118","document":"wk-form4_1786577585.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000118/wk-form4_1786577585.xml","form_type":"4"}},{"id":689263,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-12T23:33:08.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":2170,"price":27.09,"value":58785.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":51384,"source":{"system":"sec-edgar","filing":"0001933414-26-000118","document":"wk-form4_1786577585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000118/wk-form4_1786577585.xml","form_type":"4"}},{"id":689262,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-12T23:33:08.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":true,"shares":2170,"price":16,"value":34720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":53554,"source":{"system":"sec-edgar","filing":"0001933414-26-000118","document":"wk-form4_1786577585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000118/wk-form4_1786577585.xml","form_type":"4"}},{"id":705746,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-07-21T01:00:26.000Z","date":"2026-07-17","kind":"exercise","planned":true,"acquired":false,"shares":416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":3334,"derivative":{"exercise_price":15.44,"expiration_date":"2033-03-17","underlying":"Common Stock","underlying_shares":416},"source":{"system":"sec-edgar","filing":"0001672659-26-000036","document":"wk-form4_1784595624.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000036/wk-form4_1784595624.xml","form_type":"4"}},{"id":705745,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-21T01:00:26.000Z","date":"2026-07-17","kind":"sale","planned":true,"acquired":false,"shares":416,"price":26.53,"value":11036.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":51384,"source":{"system":"sec-edgar","filing":"0001672659-26-000036","document":"wk-form4_1784595624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000036/wk-form4_1784595624.xml","form_type":"4"}},{"id":705744,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-21T01:00:26.000Z","date":"2026-07-17","kind":"exercise","planned":true,"acquired":true,"shares":416,"price":15.44,"value":6423.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":51800,"source":{"system":"sec-edgar","filing":"0001672659-26-000036","document":"wk-form4_1784595624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000036/wk-form4_1784595624.xml","form_type":"4"}},{"id":708979,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-07-16T00:58:08.000Z","date":"2026-07-13","kind":"exercise","planned":true,"acquired":false,"shares":6349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.08,"expiration_date":"2032-07-11","underlying":"Common Stock","underlying_shares":6349},"source":{"system":"sec-edgar","filing":"0001933414-26-000099","document":"wk-form4_1784163485.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000099/wk-form4_1784163485.xml","form_type":"4"}},{"id":708978,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-07-16T00:58:08.000Z","date":"2026-07-13","kind":"exercise","planned":true,"acquired":false,"shares":4167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":79167,"derivative":{"exercise_price":14.25,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":4167},"source":{"system":"sec-edgar","filing":"0001933414-26-000099","document":"wk-form4_1784163485.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000099/wk-form4_1784163485.xml","form_type":"4"}},{"id":708977,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-07-16T00:58:08.000Z","date":"2026-07-13","kind":"exercise","planned":true,"acquired":false,"shares":3542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant."}],"balance_after":109792,"derivative":{"exercise_price":10.2,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":3542},"source":{"system":"sec-edgar","filing":"0001933414-26-000099","document":"wk-form4_1784163485.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000099/wk-form4_1784163485.xml","form_type":"4"}},{"id":708976,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-16T00:58:08.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":6349,"price":26.6112,"value":168954.5088,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $26.41 to $27.15. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":51384,"source":{"system":"sec-edgar","filing":"0001933414-26-000099","document":"wk-form4_1784163485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000099/wk-form4_1784163485.xml","form_type":"4"}},{"id":708975,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-16T00:58:08.000Z","date":"2026-07-13","kind":"sale","planned":true,"acquired":false,"shares":14058,"price":27.5798,"value":387716.8284,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $26.965 to $27.750. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":57733,"source":{"system":"sec-edgar","filing":"0001933414-26-000099","document":"wk-form4_1784163485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000099/wk-form4_1784163485.xml","form_type":"4"}},{"id":708974,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-16T00:58:08.000Z","date":"2026-07-13","kind":"exercise","planned":true,"acquired":true,"shares":6349,"price":1.08,"value":6856.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":71791,"source":{"system":"sec-edgar","filing":"0001933414-26-000099","document":"wk-form4_1784163485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000099/wk-form4_1784163485.xml","form_type":"4"}},{"id":708973,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-16T00:58:08.000Z","date":"2026-07-13","kind":"exercise","planned":true,"acquired":true,"shares":4167,"price":14.25,"value":59379.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":65442,"source":{"system":"sec-edgar","filing":"0001933414-26-000099","document":"wk-form4_1784163485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000099/wk-form4_1784163485.xml","form_type":"4"}},{"id":708972,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-16T00:58:08.000Z","date":"2026-07-13","kind":"exercise","planned":true,"acquired":true,"shares":3542,"price":10.2,"value":36128.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":61275,"source":{"system":"sec-edgar","filing":"0001933414-26-000099","document":"wk-form4_1784163485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000099/wk-form4_1784163485.xml","form_type":"4"}},{"id":711159,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-07-10T23:15:22.000Z","date":"2026-07-09","kind":"exercise","planned":true,"acquired":false,"shares":2171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":15194,"derivative":{"exercise_price":16,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":2171},"source":{"system":"sec-edgar","filing":"0001672659-26-000033","document":"wk-form4_1783725320.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000033/wk-form4_1783725320.xml","form_type":"4"}},{"id":711158,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-10T23:15:22.000Z","date":"2026-07-09","kind":"sale","planned":true,"acquired":false,"shares":2171,"price":30.3,"value":65781.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":57733,"source":{"system":"sec-edgar","filing":"0001672659-26-000033","document":"wk-form4_1783725320.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000033/wk-form4_1783725320.xml","form_type":"4"}},{"id":711157,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-10T23:15:22.000Z","date":"2026-07-09","kind":"exercise","planned":true,"acquired":true,"shares":2171,"price":16,"value":34736.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance includes 638 shares purchased under the Mineralys Therapeutics, Inc. 2023 Employee Stock Purchase Plan that were not previously reported."}],"balance_after":59904,"source":{"system":"sec-edgar","filing":"0001672659-26-000033","document":"wk-form4_1783725320.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000033/wk-form4_1783725320.xml","form_type":"4"}},{"id":734123,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-06-18T01:18:08.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":false,"shares":417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":3750,"derivative":{"exercise_price":15.44,"expiration_date":"2033-03-17","underlying":"Common Stock","underlying_shares":417},"source":{"system":"sec-edgar","filing":"0001933414-26-000094","document":"wk-form4_1781745485.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000094/wk-form4_1781745485.xml","form_type":"4"}},{"id":734122,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-06-18T01:18:08.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":false,"shares":4167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":83334,"derivative":{"exercise_price":14.25,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":4167},"source":{"system":"sec-edgar","filing":"0001933414-26-000094","document":"wk-form4_1781745485.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000094/wk-form4_1781745485.xml","form_type":"4"}},{"id":734121,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-06-18T01:18:08.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":3542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant."}],"balance_after":113334,"derivative":{"exercise_price":10.2,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":3542},"source":{"system":"sec-edgar","filing":"0001933414-26-000094","document":"wk-form4_1781745485.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000094/wk-form4_1781745485.xml","form_type":"4"}},{"id":734120,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-18T01:18:08.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":4584,"price":25,"value":114600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":57095,"source":{"system":"sec-edgar","filing":"0001933414-26-000094","document":"wk-form4_1781745485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000094/wk-form4_1781745485.xml","form_type":"4"}},{"id":734119,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-18T01:18:08.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":true,"shares":417,"price":15.44,"value":6438.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":61679,"source":{"system":"sec-edgar","filing":"0001933414-26-000094","document":"wk-form4_1781745485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000094/wk-form4_1781745485.xml","form_type":"4"}},{"id":734118,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-18T01:18:08.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":true,"shares":4167,"price":14.25,"value":59379.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":61262,"source":{"system":"sec-edgar","filing":"0001933414-26-000094","document":"wk-form4_1781745485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000094/wk-form4_1781745485.xml","form_type":"4"}},{"id":734117,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-18T01:18:08.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":9890,"price":23.8106,"value":235486.834,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.41 to $23.98. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":57095,"source":{"system":"sec-edgar","filing":"0001933414-26-000094","document":"wk-form4_1781745485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000094/wk-form4_1781745485.xml","form_type":"4"}},{"id":734116,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-18T01:18:08.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":3542,"price":10.2,"value":36128.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":66985,"source":{"system":"sec-edgar","filing":"0001933414-26-000094","document":"wk-form4_1781745485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000094/wk-form4_1781745485.xml","form_type":"4"}},{"id":739819,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-06-12T22:04:56.000Z","date":"2026-06-12","kind":"exercise","planned":true,"acquired":false,"shares":6349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":6349,"derivative":{"exercise_price":1.08,"expiration_date":"2032-07-11","underlying":"Common Stock","underlying_shares":6349},"source":{"system":"sec-edgar","filing":"0001672659-26-000030","document":"wk-form4_1781301893.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000030/wk-form4_1781301893.xml","form_type":"4"}},{"id":739818,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-06-12T22:04:56.000Z","date":"2026-06-10","kind":"exercise","planned":true,"acquired":false,"shares":2170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":17365,"derivative":{"exercise_price":16,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":2170},"source":{"system":"sec-edgar","filing":"0001672659-26-000030","document":"wk-form4_1781301893.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000030/wk-form4_1781301893.xml","form_type":"4"}},{"id":739817,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-12T22:04:56.000Z","date":"2026-06-12","kind":"sale","planned":true,"acquired":false,"shares":6349,"price":23.9252,"value":151901.0948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.75 to $24.02. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":63443,"source":{"system":"sec-edgar","filing":"0001672659-26-000030","document":"wk-form4_1781301893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000030/wk-form4_1781301893.xml","form_type":"4"}},{"id":739816,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-12T22:04:56.000Z","date":"2026-06-12","kind":"exercise","planned":true,"acquired":true,"shares":6349,"price":1.08,"value":6856.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":69792,"source":{"system":"sec-edgar","filing":"0001672659-26-000030","document":"wk-form4_1781301893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000030/wk-form4_1781301893.xml","form_type":"4"}},{"id":739815,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-12T22:04:56.000Z","date":"2026-06-10","kind":"sale","planned":true,"acquired":false,"shares":2170,"price":25,"value":54250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":63443,"source":{"system":"sec-edgar","filing":"0001672659-26-000030","document":"wk-form4_1781301893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000030/wk-form4_1781301893.xml","form_type":"4"}},{"id":739814,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-12T22:04:56.000Z","date":"2026-06-10","kind":"exercise","planned":true,"acquired":true,"shares":2170,"price":16,"value":34720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":65613,"source":{"system":"sec-edgar","filing":"0001672659-26-000030","document":"wk-form4_1781301893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000030/wk-form4_1781301893.xml","form_type":"4"}},{"id":772058,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-05-19T23:15:07.000Z","date":"2026-05-18","kind":"exercise","planned":true,"acquired":false,"shares":417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":4167,"derivative":{"exercise_price":15.44,"expiration_date":"2033-03-17","underlying":"Common Stock","underlying_shares":417},"source":{"system":"sec-edgar","filing":"0001933414-26-000086","document":"wk-form4_1779232505.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000086/wk-form4_1779232505.xml","form_type":"4"}},{"id":772057,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-19T23:15:07.000Z","date":"2026-05-18","kind":"sale","planned":true,"acquired":false,"shares":417,"price":27.55,"value":11488.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":63443,"source":{"system":"sec-edgar","filing":"0001933414-26-000086","document":"wk-form4_1779232505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000086/wk-form4_1779232505.xml","form_type":"4"}},{"id":772056,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-19T23:15:07.000Z","date":"2026-05-18","kind":"exercise","planned":true,"acquired":true,"shares":417,"price":15.44,"value":6438.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":63860,"source":{"system":"sec-edgar","filing":"0001933414-26-000086","document":"wk-form4_1779232505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000086/wk-form4_1779232505.xml","form_type":"4"}},{"id":780820,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-05-14T01:42:08.000Z","date":"2026-05-13","kind":"exercise","planned":true,"acquired":false,"shares":4166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":87501,"derivative":{"exercise_price":14.25,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":4166},"source":{"system":"sec-edgar","filing":"0001672659-26-000027","document":"wk-form4_1778722925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000027/wk-form4_1778722925.xml","form_type":"4"}},{"id":780819,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-05-14T01:42:08.000Z","date":"2026-05-13","kind":"exercise","planned":true,"acquired":false,"shares":3541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant."}],"balance_after":116876,"derivative":{"exercise_price":10.2,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":3541},"source":{"system":"sec-edgar","filing":"0001672659-26-000027","document":"wk-form4_1778722925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000027/wk-form4_1778722925.xml","form_type":"4"}},{"id":780818,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-05-14T01:42:08.000Z","date":"2026-05-12","kind":"exercise","planned":true,"acquired":false,"shares":6348,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":12698,"derivative":{"exercise_price":1.08,"expiration_date":"2032-07-11","underlying":"Common Stock","underlying_shares":6348},"source":{"system":"sec-edgar","filing":"0001672659-26-000027","document":"wk-form4_1778722925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000027/wk-form4_1778722925.xml","form_type":"4"}},{"id":780817,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-05-14T01:42:08.000Z","date":"2026-05-11","kind":"exercise","planned":true,"acquired":false,"shares":2171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":19535,"derivative":{"exercise_price":16,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":2171},"source":{"system":"sec-edgar","filing":"0001672659-26-000027","document":"wk-form4_1778722925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000027/wk-form4_1778722925.xml","form_type":"4"}},{"id":780816,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-14T01:42:08.000Z","date":"2026-05-13","kind":"sale","planned":true,"acquired":false,"shares":14056,"price":28.5849,"value":401789.3544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $28.0900 to $29.0208. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":63443,"source":{"system":"sec-edgar","filing":"0001672659-26-000027","document":"wk-form4_1778722925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000027/wk-form4_1778722925.xml","form_type":"4"}},{"id":780815,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-14T01:42:08.000Z","date":"2026-05-13","kind":"exercise","planned":true,"acquired":true,"shares":4166,"price":14.25,"value":59365.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":77499,"source":{"system":"sec-edgar","filing":"0001672659-26-000027","document":"wk-form4_1778722925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000027/wk-form4_1778722925.xml","form_type":"4"}},{"id":780814,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-14T01:42:08.000Z","date":"2026-05-13","kind":"exercise","planned":true,"acquired":true,"shares":3541,"price":10.2,"value":36118.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":73333,"source":{"system":"sec-edgar","filing":"0001672659-26-000027","document":"wk-form4_1778722925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000027/wk-form4_1778722925.xml","form_type":"4"}},{"id":780813,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-14T01:42:08.000Z","date":"2026-05-12","kind":"sale","planned":true,"acquired":false,"shares":6348,"price":29.3554,"value":186348.0792,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $29.14 to $29.60. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":69792,"source":{"system":"sec-edgar","filing":"0001672659-26-000027","document":"wk-form4_1778722925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000027/wk-form4_1778722925.xml","form_type":"4"}},{"id":780812,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-14T01:42:08.000Z","date":"2026-05-12","kind":"exercise","planned":true,"acquired":true,"shares":6348,"price":1.08,"value":6855.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":76140,"source":{"system":"sec-edgar","filing":"0001672659-26-000027","document":"wk-form4_1778722925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000027/wk-form4_1778722925.xml","form_type":"4"}},{"id":780811,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-14T01:42:08.000Z","date":"2026-05-11","kind":"sale","planned":true,"acquired":false,"shares":2171,"price":29.71,"value":64500.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":69792,"source":{"system":"sec-edgar","filing":"0001672659-26-000027","document":"wk-form4_1778722925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000027/wk-form4_1778722925.xml","form_type":"4"}},{"id":780810,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-14T01:42:08.000Z","date":"2026-05-11","kind":"exercise","planned":true,"acquired":true,"shares":2171,"price":16,"value":34736.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":71963,"source":{"system":"sec-edgar","filing":"0001672659-26-000027","document":"wk-form4_1778722925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000027/wk-form4_1778722925.xml","form_type":"4"}},{"id":803715,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-04-21T22:59:35.000Z","date":"2026-04-17","kind":"exercise","planned":true,"acquired":false,"shares":416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":4584,"derivative":{"exercise_price":15.44,"expiration_date":"2033-03-17","underlying":"Common Stock","underlying_shares":416},"source":{"system":"sec-edgar","filing":"0001672659-26-000024","document":"wk-form4_1776812373.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000024/wk-form4_1776812373.xml","form_type":"4"}},{"id":803714,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-21T22:59:35.000Z","date":"2026-04-17","kind":"sale","planned":true,"acquired":false,"shares":416,"price":31.33,"value":13033.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":69792,"source":{"system":"sec-edgar","filing":"0001672659-26-000024","document":"wk-form4_1776812373.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000024/wk-form4_1776812373.xml","form_type":"4"}},{"id":803713,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-21T22:59:35.000Z","date":"2026-04-17","kind":"exercise","planned":true,"acquired":true,"shares":416,"price":15.44,"value":6423.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":70208,"source":{"system":"sec-edgar","filing":"0001672659-26-000024","document":"wk-form4_1776812373.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000024/wk-form4_1776812373.xml","form_type":"4"}},{"id":808169,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-04-16T01:45:26.000Z","date":"2026-04-13","kind":"exercise","planned":true,"acquired":false,"shares":4167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":91667,"derivative":{"exercise_price":14.25,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":4167},"source":{"system":"sec-edgar","filing":"0001933414-26-000076","document":"wk-form4_1776303923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000076/wk-form4_1776303923.xml","form_type":"4"}},{"id":808168,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-04-16T01:45:26.000Z","date":"2026-04-13","kind":"exercise","planned":true,"acquired":false,"shares":3542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant."}],"balance_after":120417,"derivative":{"exercise_price":10.2,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":3542},"source":{"system":"sec-edgar","filing":"0001933414-26-000076","document":"wk-form4_1776303923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000076/wk-form4_1776303923.xml","form_type":"4"}},{"id":808167,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-04-16T01:45:26.000Z","date":"2026-04-13","kind":"exercise","planned":true,"acquired":false,"shares":6349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":19046,"derivative":{"exercise_price":1.08,"expiration_date":"2032-07-11","underlying":"Common Stock","underlying_shares":6349},"source":{"system":"sec-edgar","filing":"0001933414-26-000076","document":"wk-form4_1776303923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000076/wk-form4_1776303923.xml","form_type":"4"}},{"id":808166,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-16T01:45:26.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":6348,"price":27.66,"value":175585.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":69792,"source":{"system":"sec-edgar","filing":"0001933414-26-000076","document":"wk-form4_1776303923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000076/wk-form4_1776303923.xml","form_type":"4"}},{"id":808165,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-16T01:45:26.000Z","date":"2026-04-13","kind":"sale","planned":true,"acquired":false,"shares":14058,"price":26.5391,"value":373086.6678,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $26.3676 to $26.8400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":76140,"source":{"system":"sec-edgar","filing":"0001933414-26-000076","document":"wk-form4_1776303923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000076/wk-form4_1776303923.xml","form_type":"4"}},{"id":808164,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-16T01:45:26.000Z","date":"2026-04-13","kind":"exercise","planned":true,"acquired":true,"shares":4167,"price":14.25,"value":59379.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":90198,"source":{"system":"sec-edgar","filing":"0001933414-26-000076","document":"wk-form4_1776303923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000076/wk-form4_1776303923.xml","form_type":"4"}},{"id":808163,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-16T01:45:26.000Z","date":"2026-04-13","kind":"exercise","planned":true,"acquired":true,"shares":3542,"price":10.2,"value":36128.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":86031,"source":{"system":"sec-edgar","filing":"0001933414-26-000076","document":"wk-form4_1776303923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000076/wk-form4_1776303923.xml","form_type":"4"}},{"id":808162,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-16T01:45:26.000Z","date":"2026-04-13","kind":"exercise","planned":true,"acquired":true,"shares":6349,"price":1.08,"value":6856.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":82489,"source":{"system":"sec-edgar","filing":"0001933414-26-000076","document":"wk-form4_1776303923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000076/wk-form4_1776303923.xml","form_type":"4"}},{"id":809625,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-04-14T01:13:48.000Z","date":"2026-04-09","kind":"exercise","planned":true,"acquired":false,"shares":2170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":21706,"derivative":{"exercise_price":16,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":2170},"source":{"system":"sec-edgar","filing":"0001672659-26-000020","document":"wk-form4_1776129225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000020/wk-form4_1776129225.xml","form_type":"4"}},{"id":809624,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-14T01:13:48.000Z","date":"2026-04-09","kind":"sale","planned":true,"acquired":false,"shares":2170,"price":27.38,"value":59414.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":76140,"source":{"system":"sec-edgar","filing":"0001672659-26-000020","document":"wk-form4_1776129225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000020/wk-form4_1776129225.xml","form_type":"4"}},{"id":809623,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-14T01:13:48.000Z","date":"2026-04-09","kind":"exercise","planned":true,"acquired":true,"shares":2170,"price":16,"value":34720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":78310,"source":{"system":"sec-edgar","filing":"0001672659-26-000020","document":"wk-form4_1776129225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000020/wk-form4_1776129225.xml","form_type":"4"}},{"id":837941,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-03-17T20:51:17.000Z","date":"2026-03-17","kind":"exercise","planned":true,"acquired":false,"shares":417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":5000,"derivative":{"exercise_price":15.44,"expiration_date":"2033-03-17","underlying":"Common Stock","underlying_shares":417},"source":{"system":"sec-edgar","filing":"0001672659-26-000018","document":"wk-form4_1773780674.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000018/wk-form4_1773780674.xml","form_type":"4"}},{"id":837940,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:51:17.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":417,"price":25.65,"value":10696.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":76140,"source":{"system":"sec-edgar","filing":"0001672659-26-000018","document":"wk-form4_1773780674.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000018/wk-form4_1773780674.xml","form_type":"4"}},{"id":837939,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:51:17.000Z","date":"2026-03-17","kind":"exercise","planned":true,"acquired":true,"shares":417,"price":15.44,"value":6438.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":76557,"source":{"system":"sec-edgar","filing":"0001672659-26-000018","document":"wk-form4_1773780674.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000018/wk-form4_1773780674.xml","form_type":"4"}},{"id":841617,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-03-16T21:20:12.000Z","date":"2026-03-13","kind":"exercise","planned":true,"acquired":false,"shares":4167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":95834,"derivative":{"exercise_price":14.25,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":4167},"source":{"system":"sec-edgar","filing":"0001933414-26-000058","document":"wk-form4_1773696009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000058/wk-form4_1773696009.xml","form_type":"4"}},{"id":841616,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-03-16T21:20:12.000Z","date":"2026-03-13","kind":"exercise","planned":true,"acquired":false,"shares":3542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant."}],"balance_after":123959,"derivative":{"exercise_price":10.2,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":3542},"source":{"system":"sec-edgar","filing":"0001933414-26-000058","document":"wk-form4_1773696009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000058/wk-form4_1773696009.xml","form_type":"4"}},{"id":841615,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-03-16T21:20:12.000Z","date":"2026-03-12","kind":"exercise","planned":true,"acquired":false,"shares":6348,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":25395,"derivative":{"exercise_price":1.08,"expiration_date":"2032-07-11","underlying":"Common Stock","underlying_shares":6348},"source":{"system":"sec-edgar","filing":"0001933414-26-000058","document":"wk-form4_1773696009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000058/wk-form4_1773696009.xml","form_type":"4"}},{"id":841614,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:20:12.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":253,"price":27.82,"value":7038.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":76140,"source":{"system":"sec-edgar","filing":"0001933414-26-000058","document":"wk-form4_1773696009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000058/wk-form4_1773696009.xml","form_type":"4"}},{"id":841613,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:20:12.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":3079,"price":27.3675,"value":84264.5325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $26.772 to $27.720. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."}],"balance_after":76393,"source":{"system":"sec-edgar","filing":"0001933414-26-000058","document":"wk-form4_1773696009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000058/wk-form4_1773696009.xml","form_type":"4"}},{"id":841612,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:20:12.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":10726,"price":25.9111,"value":277922.4586,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $25.77 to $26.76. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":79472,"source":{"system":"sec-edgar","filing":"0001933414-26-000058","document":"wk-form4_1773696009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000058/wk-form4_1773696009.xml","form_type":"4"}},{"id":841611,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:20:12.000Z","date":"2026-03-13","kind":"exercise","planned":true,"acquired":true,"shares":4167,"price":14.25,"value":59379.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":90198,"source":{"system":"sec-edgar","filing":"0001933414-26-000058","document":"wk-form4_1773696009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000058/wk-form4_1773696009.xml","form_type":"4"}},{"id":841610,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:20:12.000Z","date":"2026-03-13","kind":"exercise","planned":true,"acquired":true,"shares":3542,"price":10.2,"value":36128.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":86031,"source":{"system":"sec-edgar","filing":"0001933414-26-000058","document":"wk-form4_1773696009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000058/wk-form4_1773696009.xml","form_type":"4"}},{"id":841609,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:20:12.000Z","date":"2026-03-12","kind":"sale","planned":true,"acquired":false,"shares":6348,"price":27.3705,"value":173747.934,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $27.02 to $27.92. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":82489,"source":{"system":"sec-edgar","filing":"0001933414-26-000058","document":"wk-form4_1773696009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000058/wk-form4_1773696009.xml","form_type":"4"}},{"id":841608,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:20:12.000Z","date":"2026-03-12","kind":"exercise","planned":true,"acquired":true,"shares":6348,"price":1.08,"value":6855.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":88837,"source":{"system":"sec-edgar","filing":"0001933414-26-000058","document":"wk-form4_1773696009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000058/wk-form4_1773696009.xml","form_type":"4"}},{"id":850944,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-03-10T21:48:35.000Z","date":"2026-03-09","kind":"exercise","planned":true,"acquired":false,"shares":2171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":23876,"derivative":{"exercise_price":16,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":2171},"source":{"system":"sec-edgar","filing":"0001672659-26-000015","document":"wk-form4_1773179312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000015/wk-form4_1773179312.xml","form_type":"4"}},{"id":850943,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-10T21:48:35.000Z","date":"2026-03-09","kind":"sale","planned":true,"acquired":false,"shares":2171,"price":26.84,"value":58269.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":82489,"source":{"system":"sec-edgar","filing":"0001672659-26-000015","document":"wk-form4_1773179312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000015/wk-form4_1773179312.xml","form_type":"4"}},{"id":850942,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-10T21:48:35.000Z","date":"2026-03-09","kind":"exercise","planned":true,"acquired":true,"shares":2171,"price":16,"value":34736.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":84660,"source":{"system":"sec-edgar","filing":"0001672659-26-000015","document":"wk-form4_1773179312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000015/wk-form4_1773179312.xml","form_type":"4"}},{"id":890697,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-02-21T00:46:56.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":51300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant"}],"balance_after":51300,"derivative":{"exercise_price":28.06,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":51300},"source":{"system":"sec-edgar","filing":"0001933414-26-000038","document":"wk-form4_1771634813.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000038/wk-form4_1771634813.xml","form_type":"4"}},{"id":890696,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-21T00:46:56.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":38400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting. The RSUs vest in annual installments over a period of four years, with 1/4th of the total shares underlying the RSU vesting on each one-year anniversary of the date of grant."}],"balance_after":82489,"source":{"system":"sec-edgar","filing":"0001933414-26-000038","document":"wk-form4_1771634813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000038/wk-form4_1771634813.xml","form_type":"4"}},{"id":901009,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-02-17T23:56:37.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":false,"shares":417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":5417,"derivative":{"exercise_price":15.44,"expiration_date":"2033-03-17","underlying":"Common Stock","underlying_shares":417},"source":{"system":"sec-edgar","filing":"0001672659-26-000013","document":"wk-form4_1771372594.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000013/wk-form4_1771372594.xml","form_type":"4"}},{"id":901008,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-17T23:56:37.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":417,"price":27.59,"value":11505.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":44089,"source":{"system":"sec-edgar","filing":"0001672659-26-000013","document":"wk-form4_1771372594.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000013/wk-form4_1771372594.xml","form_type":"4"}},{"id":901007,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-17T23:56:37.000Z","date":"2026-02-17","kind":"exercise","planned":true,"acquired":true,"shares":417,"price":15.44,"value":6438.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":44506,"source":{"system":"sec-edgar","filing":"0001672659-26-000013","document":"wk-form4_1771372594.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000013/wk-form4_1771372594.xml","form_type":"4"}},{"id":905215,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-02-14T00:25:17.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":false,"shares":4166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":100001,"derivative":{"exercise_price":14.25,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":4166},"source":{"system":"sec-edgar","filing":"0001672659-26-000011","document":"wk-form4_1771028714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000011/wk-form4_1771028714.xml","form_type":"4"}},{"id":905214,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-02-14T00:25:17.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":false,"shares":3541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant."}],"balance_after":127501,"derivative":{"exercise_price":10.2,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":3541},"source":{"system":"sec-edgar","filing":"0001672659-26-000011","document":"wk-form4_1771028714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000011/wk-form4_1771028714.xml","form_type":"4"}},{"id":905213,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-02-14T00:25:17.000Z","date":"2026-02-12","kind":"exercise","planned":true,"acquired":false,"shares":6349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":31743,"derivative":{"exercise_price":1.08,"expiration_date":"2032-07-11","underlying":"Common Stock","underlying_shares":6349},"source":{"system":"sec-edgar","filing":"0001672659-26-000011","document":"wk-form4_1771028714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000011/wk-form4_1771028714.xml","form_type":"4"}},{"id":905212,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-14T00:25:17.000Z","date":"2026-02-13","kind":"sale","planned":true,"acquired":false,"shares":6348,"price":27.5835,"value":175100.058,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $27.3300 to $28.0000. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4."}],"balance_after":44089,"source":{"system":"sec-edgar","filing":"0001672659-26-000011","document":"wk-form4_1771028714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000011/wk-form4_1771028714.xml","form_type":"4"}},{"id":905211,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-14T00:25:17.000Z","date":"2026-02-13","kind":"sale","planned":true,"acquired":false,"shares":4166,"price":27.33,"value":113856.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":50437,"source":{"system":"sec-edgar","filing":"0001672659-26-000011","document":"wk-form4_1771028714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000011/wk-form4_1771028714.xml","form_type":"4"}},{"id":905210,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-14T00:25:17.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":true,"shares":4166,"price":14.25,"value":59365.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":54603,"source":{"system":"sec-edgar","filing":"0001672659-26-000011","document":"wk-form4_1771028714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000011/wk-form4_1771028714.xml","form_type":"4"}},{"id":905209,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-14T00:25:17.000Z","date":"2026-02-13","kind":"sale","planned":true,"acquired":false,"shares":3541,"price":27.33,"value":96775.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":50437,"source":{"system":"sec-edgar","filing":"0001672659-26-000011","document":"wk-form4_1771028714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000011/wk-form4_1771028714.xml","form_type":"4"}},{"id":905208,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-14T00:25:17.000Z","date":"2026-02-13","kind":"exercise","planned":true,"acquired":true,"shares":3541,"price":10.2,"value":36118.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":53978,"source":{"system":"sec-edgar","filing":"0001672659-26-000011","document":"wk-form4_1771028714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000011/wk-form4_1771028714.xml","form_type":"4"}},{"id":905207,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-14T00:25:17.000Z","date":"2026-02-12","kind":"sale","planned":true,"acquired":false,"shares":521,"price":29.6387,"value":15441.7627,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $29.5870 to $29.6600. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":50437,"source":{"system":"sec-edgar","filing":"0001672659-26-000011","document":"wk-form4_1771028714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000011/wk-form4_1771028714.xml","form_type":"4"}},{"id":905206,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-14T00:25:17.000Z","date":"2026-02-12","kind":"sale","planned":true,"acquired":false,"shares":5828,"price":28.9353,"value":168634.9284,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $28.5200 to $29.4200. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":50958,"source":{"system":"sec-edgar","filing":"0001672659-26-000011","document":"wk-form4_1771028714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000011/wk-form4_1771028714.xml","form_type":"4"}},{"id":905205,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-14T00:25:17.000Z","date":"2026-02-12","kind":"exercise","planned":true,"acquired":true,"shares":6349,"price":1.08,"value":6856.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":56786,"source":{"system":"sec-edgar","filing":"0001672659-26-000011","document":"wk-form4_1771028714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000011/wk-form4_1771028714.xml","form_type":"4"}},{"id":909938,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-02-11T23:58:56.000Z","date":"2026-02-09","kind":"exercise","planned":true,"acquired":false,"shares":2171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":26047,"derivative":{"exercise_price":16,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":2171},"source":{"system":"sec-edgar","filing":"0001933414-26-000007","document":"wk-form4_1770854332.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000007/wk-form4_1770854332.xml","form_type":"4"}},{"id":909937,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-11T23:58:56.000Z","date":"2026-02-09","kind":"sale","planned":true,"acquired":false,"shares":2171,"price":30.21,"value":65585.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":50437,"source":{"system":"sec-edgar","filing":"0001933414-26-000007","document":"wk-form4_1770854332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000007/wk-form4_1770854332.xml","form_type":"4"}},{"id":909936,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-11T23:58:56.000Z","date":"2026-02-09","kind":"exercise","planned":true,"acquired":true,"shares":2171,"price":16,"value":34736.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":52608,"source":{"system":"sec-edgar","filing":"0001933414-26-000007","document":"wk-form4_1770854332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000193341426000007/wk-form4_1770854332.xml","form_type":"4"}},{"id":935390,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-01-21T01:33:56.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":false,"shares":416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":5834,"derivative":{"exercise_price":15.44,"expiration_date":"2033-03-17","underlying":"Common Stock","underlying_shares":416},"source":{"system":"sec-edgar","filing":"0001672659-26-000008","document":"wk-form4_1768959233.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000008/wk-form4_1768959233.xml","form_type":"4"}},{"id":935389,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-21T01:33:56.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":416,"price":32.1,"value":13353.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":50437,"source":{"system":"sec-edgar","filing":"0001672659-26-000008","document":"wk-form4_1768959233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000008/wk-form4_1768959233.xml","form_type":"4"}},{"id":935388,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-21T01:33:56.000Z","date":"2026-01-20","kind":"exercise","planned":true,"acquired":true,"shares":416,"price":15.44,"value":6423.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."}],"balance_after":50853,"source":{"system":"sec-edgar","filing":"0001672659-26-000008","document":"wk-form4_1768959233.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000008/wk-form4_1768959233.xml","form_type":"4"}},{"id":938502,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-01-16T00:07:36.000Z","date":"2026-01-13","kind":"exercise","planned":true,"acquired":false,"shares":4167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":104167,"derivative":{"exercise_price":14.25,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":4167},"source":{"system":"sec-edgar","filing":"0001672659-26-000006","document":"wk-form4_1768522053.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000006/wk-form4_1768522053.xml","form_type":"4"}},{"id":938501,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-01-16T00:07:36.000Z","date":"2026-01-13","kind":"exercise","planned":true,"acquired":false,"shares":3542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant."}],"balance_after":131042,"derivative":{"exercise_price":10.2,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":3542},"source":{"system":"sec-edgar","filing":"0001672659-26-000006","document":"wk-form4_1768522053.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000006/wk-form4_1768522053.xml","form_type":"4"}},{"id":938500,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":24112,"kind":"person","name":"Rodman David Malcom","position":1,"cik":"0001672659","reported_name":"Rodman David Malcom","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-16T00:07:36.000Z","date":"2026-01-14","kind":"sale","planned":true,"acquired":false,"shares":11367,"price":32.6071,"value":370644.9057,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $31.99 to $32.91. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":50437,"source":{"system":"sec-edgar","filing":"0001672659-26-000006","document":"wk-form4_1768522053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1672659/000167265926000006/wk-form4_1768522053.xml","form_type":"4"}}],"next_cursor":"2026-01-16T00:07:36.000000Z,938500"}